Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

(OP:ACUT)

1.090 +0.225 (+26.06%)
Streaming Delayed Price Updated: 3:39 PM EDT, Jun 13, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 22,094
Open 0.8680
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close 0.8647
Today's Range 0.8680 - 1.170
52wk Range 0.2200 - 1.170
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
AccuStem Sciences, Inc. Announces Chairman Purchase of Shares
From AccuStem Sciences, Inc.
Via GlobeNewswire
AccuStem Sciences, Inc. and EmeritusDX Announce Partnership to Commercialize MSC Test for Lung Cancer Screening
From AccuStem Sciences, Inc.
Via GlobeNewswire

Performance

YTD
+111.4%
+111.4%
1 Month
+82.2%
+82.2%
3 Month
+199.9%
+199.9%
6 Month
+350.4%
+350.4%
1 Year
+178.7%
+178.7%

More News

Read More
AccuStem Sciences, Inc. Announces Chairman Purchase of Shares
From AccuStem Sciences, Inc.
Via GlobeNewswire
AccuStem Sciences, Inc. Signs Agreement to Access Blood Samples from Lung Cancer Screening Trial to Expedite MSC Commercialization Plan
From AccuStem Sciences, Inc.
Via GlobeNewswire
AccuStem Sciences, Inc. Announces Chairman Purchase of Shares
From AccuStem Sciences, Inc.
Via GlobeNewswire
AccuStem Sciences, Inc. Announces Chairman Purchase of Shares
From AccuStem Sciences, Inc.
Via GlobeNewswire
AccuStem Sciences to Offer its MSC Blood Test to Lung Cancer Screening Programs in the United States
From AccuStem Sciences, Inc.
Via GlobeNewswire
AccuStem Sciences, Inc. Announces Acquisition of Proprietary MSC Lung Cancer Screening Test
From AccuStem Sciences, Inc.
Via GlobeNewswire
AccuStem Sciences, Inc. Announces Chairman Purchase of Shares
From AccuStem Sciences, Inc
Via GlobeNewswire
AccuStem Sciences, Inc. and EmeritusDX Announce Joint Product Development Agreement and Strategic Partnership
From AccuStem Sciences, Inc
Via GlobeNewswire
AccuStem Sciences, Inc. Extends and Broadens Partnership with Instituto Europeo di Oncologia (IEO) Enabling its Strategic Approach to Address Unanswered Clinical Questions in Early Stage Breast Cancer
From AccuStem Sciences, Inc
Via GlobeNewswire
Goldman Small Cap Research Publishes New Research Report on AccuStem Sciences, Inc.
Via ACCESSWIRE
AccuStem Sciences, Inc. Announces Collaboration Agreement with University Hospitals
From AccuStem Sciences, Inc.
Via GlobeNewswire
AccuStem Announce Strategic Clinical and Operational Partnership
From AccuStem Sciences, Inc.
Via GlobeNewswire
AccuStem Sciences Announces Extension of its US Patent Application for SPARE Test for Patients with Breast Cancer
From AccuStem Sciences, Inc.
Via GlobeNewswire
AccuStem Sciences, Inc. Announces Chairman Purchase of Shares
From AccuStem Sciences, Inc.
Via GlobeNewswire
AccuStem Sciences, Inc. Announces Chairman Purchase of Shares
From AccuStem Sciences, Inc.
Via GlobeNewswire
AccuStem Sciences Announces Appointment of Sean McDonald to Board of Directors
From AccuStem Sciences, Inc.
Via GlobeNewswire
AccuStem Announces Adjournment of Annual Meeting of Stockholders
From AccuStem Sciences, Inc.
Via GlobeNewswire
4 Stocks Under $2 Insiders Are Aggressively Buying
Via Benzinga

Frequently Asked Questions

Is ACUT publicly traded?
Yes, ACUT is publicly traded.
What exchange does ACUT trade on?
ACUT trades on the OTC Traded
What is the ticker symbol for ACUT?
The ticker symbol for ACUT is ACUT on the OTC Traded
What is the current price of ACUT?
The current price of ACUT is 1.090
When was ACUT last traded?
The last trade of ACUT was at 06/13/25 03:39 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.